In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory ...

CAMBRIDGE, Mass. - Ernexa Therapeutics (NASDAQ:ERNA) announced Tuesday the successful completion of its Pre-Investigational New Drug Application meeting with the U.S. Food and Drug Administration for ...

Humans don’t hibernate in winter, but they do get weaker and sadder. So, January is not a natural time for those in the ...

Registrational myositis trial actively enrolling with planned 17-patient cohort and 2027 rese-cel BLA submission - including an outpatient dosing option using a single weight-based dose IND amendment ...

New wireless carriers show how retail consumer segmentation is shifting toward identity, behavior, trust, and affiliation, ...

He consults at Nuffield Health Leeds and Nuffield Health York. Arrange an in-person or video consultation at mrkailasmunot.co ...

Oncolytics also recently expanded its Scientific Advisory Board with globally recognized experts from Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center, positioning the company for ...

The innovation district around Kings Cross and Euston has the potential to grow into the UK's version of Kendall Square, writes Geraint Rees.

Universal Quantum has staked its reputation on the trapped-ion approach, allowing it to scale in the quickest and most ...

Independent Analysis Examines Photobiomodulation Format Differences, 660nm and 850nm Wavelength Science, and Consumer ...

Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...